Psoriasis Risk Rises with TNF Inhibitor Use in Pediatric Inflammatory Diseases

November 27, 2019

Children with inflammatory bowel disease, juvenile idiopathic arthritis, and chronic noninfectious osteomyelitis who were treated with TNF inhibitors had a higher rate of incident psoriasis than those not exposed to these biologics, say researchers recently writing in Arthritis Care & Research.

Severe Psoriasis Associated with Increased Risk of Advanced Liver Fibrosis

July 15, 2019

Patients with severe psoriasis are also at a significant increase for developing advanced liver fibrosis, new research shows

Risk of Infection in Psoriasis Lower with Some Biologics

May 29, 2019

Psoriasis patients have a lower risk of serious infection with specific biologic and non-biologic medications than with methotrexate, based on new research results.

Lower Heart Disease Risk in Psoriasis and PsA with Biologics DMARDs

February 25, 2019

Biological therapies prescribed for rheumatic diseases may also reduce their long-term risks of cardiovascular diseases (CVD), new research shows.

Methotrexate Use in Psoriasis with Arthritis Revisited

February 13, 2019

A new study in JAMA Dermatology raises an interesting question for physicians who treat psoriasis patients. Does methotrexate work best in patients with plaque psoriasis alone or patients who have both psoriasis and arthritis?

Online Care as Effective as In-Person Care for Psoriasis

January 28, 2019

Online care and in-person care are equally effective at improving psoriasis symptoms, shows a study published in JAMA Network Open.

CV Risk in Rheumatic Disease

January 23, 2019

(1) Inflammatory diseases raise risk of venous thromboembolism; (2) antiphospholipid antibodies play a role in MI; (3) persistent hyperuricemia predicts mortality.

6 New Medications for Rheumatology in 2018

December 21, 2018

Here’s a brief look at 6 medications for rheumatologic disorders that were newly approved in the second half of 2018.

Psoriasis in Primary Care: A Quiz

August 22, 2018

How is psoriasis best managed in the primary care setting? Take this quick quiz to test your knowledge.

7 New Drugs for Rheumatology in 2018

July 30, 2018

Here’s a brief look at medications for rheumatologic disorders that were approved or granted a new indication in 2018.

Diet and Psoriatic Disease: 5 Questions Physicians Often Ask

July 12, 2018

New recommendations from the National Psoriasis Foundation offer answers. The express goal of these guidelines: to reduce disease severity through proper nutrition.

Hot Topics in Psoriatic Arthritis: Updates From EULAR 2018

July 09, 2018

Two recent studies focus on the risks of osteoporosis and cardiovascular disease in patients on the psoriatic arthritis/psoriasis spectrum.

Tendinopathy Afoot in Psoriasis Even without PsA

June 19, 2018

A diagnostic challenge: foot and ankle tendinopathy or enthesopathy in patients with psoriasis who do not have psoriatic arthritis.

Certolizumab Gets FDA Nod for Moderate to Severe Plaque Psoriasis in Adults

May 29, 2018

The approval makes Cimzia the first Fc-free, PEGylated anti-TNF treatment option for this indication.

Psoriasis: A Primary Care Primer

April 30, 2018

Most patients seen in primary care have mild to moderate plaque psoriasis, which is usually treatable with topical therapies.

Tildrakizumab Gets FDA Nod for Moderate to Severe Plaque Psoriasis

March 23, 2018

This novel interleukin-23 inhibitor targets psoriatic inflammation.

6 Top Rheumatology Apps for Patients

March 20, 2018

Help your patients help themselves. Take a look at 6 rheumatology apps you can discuss at the next visit.

Novel Biologics for Psoriasis

March 12, 2018

In late-breaking clinical trials, 3 novel biologic drugs show promise for the treatment of moderate to severe plaque psoriasis.

Topical Cannabis: Aye, There's the Rub

February 21, 2018

Another potential indication for medical marijuana: psoriasis.